Abivax (ABVX) Shares Issued (2024 - 2026)
Abivax (ABVX) recorded quarterly Shares Issued of $26927.1 in Q1 2026, up 2351.89% quarter-over-quarter from $1098.2 in Q3 2024.
Abivax (ABVX) Shares Issued (2024 - 2026) Analysis & Trends
Abivax's Shares Issued history runs 2 years deep, the most recent figure standing at $26927.1 for Q1 2026.
- In Q1 2026, Shares Issued changed N/A year-over-year to $26927.1; the TTM figure through Mar 2026 stood at $26927.1 (changed N/A YoY), while the FY2025 annual figure was $754.4 million, changed N/A from the prior year.
- Shares Issued was $26927.1 for Q1 2026 at Abivax, up from $1098.2 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $26927.1 in Q1 2026 to a low of $1098.2 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 26,927.15 |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 163.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,927.15 |
| Mar 31, 2026 | 26,927.15 |
| Sep 30, 2024 | 1,098.22 |
| Sep 30, 2024 | 1,098.22 |